Inflammatory bowel disease incidence: up, down or unchanged?
Open accessThe DOI matches its Crossref record.
Abstract
One of the few aspects of the epidemiology of inflammatory bowel disease (IBD) that seems indisputable is the emergence of both ulcerative colitis and Crohn’s disease in the economically developed nations of Western Europe and North America during the past century.1 Some of the apparent increase in incidence undoubtedly reflects a receding tide of mimicking infectious diseases and developments in endoscopic and other diagnostic techniques. Nevertheless, most epidemiologists accept that there were considerable real increases in ulcerative colitis incidence during the first half of this century and of Crohn’s disease incidence during the middle half-century in these countries.2 As the millennium approaches, are the incidences of each disease continuing to increase? Some reports suggest they are, whereas claims that Crohn’s disease incidence is no longer increasing can provoke a rapid response from some clinicians.3-6 At a time when basic science is making progress by leaps and bounds, why should such an apparently simple epidemiological question prove so difficult to answer, and does it matter? Assessing time trends in the incidence of most chronic diseases is difficult and IBD poses particular problems. Firstly, the data routinely collected on mortality and morbidity from IBD are of little help. In most countries over 75% of deaths attributed to IBD are in the elderly and mortality rates are a twentieth or less of the incidence figures for the same period. Although national mortality statistics show a broad correlation with individual incidence studies from those countries, the relation between mortality and incidence within countries is weak, such that during the 1950s and 1960s mortality rates from Crohn’s disease in England and Wales and the USA showed a small less than twofold increase when individual studies of Crohn’s disease incidence were showing much larger increases.7 8 Over the same period ulcerative colitis …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.001 · Cited by 4,833
Guidelines for the management of inflammatory bowel disease in adults
Mowat, C., Cole, A., Windsor, A., Ahmad, T., Arnott, I., Driscoll, R., Mitton, S., Orchard, T., Rutter, M., Younge, L., et al. (2011) · Gut · doi:10.1136/gut.2010.224154 · Cited by 1,419
Management of Crohn's Disease in Adults
Lichtenstein, G. R., Hanauer, S. B., & Sandborn, W. J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.168 · Cited by 1,173
Loftus, C. G., Loftus, E. V., Harmsen, S. W., Zinsmeister, A. R., Tremaine, W. J., Melton, J. L., & Sandborn, W. J. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20029 · Cited by 644
The Epidemiology of Inflammatory Bowel Disease in Canada: A Population-Based Study
Bernstein, C. N., Wajda, A., Svenson, L. W., MacKenzie, A., Koehoorn, M., Jackson, M., Fedorak, R., Israel, D., & Blanchard, J. F. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00603.x · Cited by 636
Clements, O., Eliahoo, J., Kim, J. U., Taylor-Robinson, S. D., & Khan, S. A. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.09.007 · Cited by 550
Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival
Loftus, E. V., Silverstein, M. D., Sandborn, W. J., Tremaine, W. J., Harmsen, W. S., & Zinsmeister, A. R. (2000) · Gut · doi:10.1136/gut.46.3.336 · Cited by 492
“Many centres, predominantly in northern Europe, have reported stable or slightly increasing incidence rates for ulcerative colitis over the past five decades, 6–22 in contrast to a sharp increase in incidence followed by a plateau beginning in the 1970s for Crohn’s disease.”
BackgroundLoftus, E. V., Schoenfeld, P., & Sandborn, W. J. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01140.x · Cited by 461
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut
Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi, E., Tsuboi, K., Sugimoto, Y., Kobayashi, T., Miyachi, Y., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214459 · Cited by 418
Inflammatory Bowel Disease: An Expanding Global Health Problem
M'koma, A. E. (2013) · Clinical Medicine Insights: Gastroenterology · doi:10.4137/cgast.s12731 · Cited by 359
Specificities of inflammatory bowel disease in childhood
Griffiths, A. M. (2004) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2004.01.002 · Cited by 359
Inflammatory bowel disease: epidemiology and management in an English general practice population
Rubin, G. P., Hungin, A. P. S., Kelly, P. J., & Ling, J. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00886.x · Cited by 315
Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study
Bassi, A., Dodd, S., Williamson, P., & Bodger, K. (2004) · Gut · doi:10.1136/gut.2004.041616 · Cited by 309
The Inflammatory Bowel Diseases and Ambient Air Pollution: A Novel Association
Kaplan, G. G., Hubbard, J., Korzenik, J., Sands, B. E., Panaccione, R., Ghosh, S., Wheeler, A. J., & Villeneuve, P. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.252 · Cited by 287
Management of Crohn's disease in adults
Hanauer, S. B., Sandborn, W., & The Practice Parameters Committee of the American College of Gastroenterology (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03671.x · Cited by 261
Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990–2001
Hildebrand, H., Finkel, Y., Grahnquist, L., Lindholm, J., Ekbom, A., & Askling, J. (2003) · Gut · doi:10.1136/gut.52.10.1432 · Cited by 231
Rising Incidence of Inflammatory Bowel Disease Among Children: A 12‐year Study
Malaty, H. M., Fan, X., Opekun, A. R., Thibodeaux, C., & Ferry, G. D. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181b99baa · Cited by 220
Inflammatory bowel disease in early childhood and adolescence: special considerations
Mamula, P., Markowitz, J. E., & Baldassano, R. N. (2003) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(03)00046-3 · Cited by 183
“The incidence of ulcerative colitis showed a more stable pattern, although again with a tendency for an increase over the years [10,14].”
BackgroundResultIncidence of inflammatory bowel disease in finnish children, 1987–2003
Turunen, P., Kolho, K.-L., Auvinen, A., Iltanen, S., Huhtala, H., & Ashorn, M. (2006) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200608000-00002 · Cited by 174
Roberts, S. E., Williams, J. G., Yeates, D., & Goldacre, M. J. (2007) · BMJ · doi:10.1136/bmj.39345.714039.55 · Cited by 169
“A sharp increase in the incidence of Crohn's disease occurred from the 1950s to the 1980s in the United Kingdom”
BackgroundGhione, S., Sarter, H., Fumery, M., Armengol-Debeir, L., Savoye, G., Ley, D., Spyckerelle, C., Pariente, B., Peyrin-Biroulet, L., Turck, D., et al. (2018) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.228 · Cited by 168
The incidence of Crohn’s disease in Cardiff over the last 75 years: an update for 1996–2005
GUNESH, S., THOMAS, G. A. O., WILLIAMS, G. T., ROBERTS, A., & HAWTHORNE, A. B. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03576.x · Cited by 89
Włodarczyk, M., Sobolewska-Włodarczyk, A., Stec-Michalska, K., Fichna, J., & Wiśniewska-Jarosińska, M. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.04.008 · Cited by 11
Metadata
- Authors
- LOGAN, R. F. A.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1998-03-01
- Volume
- 42
- Issue
- 3
- Pages
- 309-311
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W1992284995
- Cited by
- 157
- References
- 0
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.